Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul;34(7):4821-4827.
doi: 10.1007/s00330-023-10411-x. Epub 2023 Dec 7.

Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science Committee

Affiliations
Review

Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science Committee

Aart J van der Molen et al. Eur Radiol. 2024 Jul.

Abstract

The Contrast Media Safety Committee of the European Society of Urogenital Radiology has, together with the Preanalytical Phase Working Group of the EFLM Science Committee, reviewed the literature and updated its recommendations to increase awareness and provide insight into these interferences. CLINICAL RELEVANCE STATEMENT: Contrast Media may interfere with clinical laboratory tests. Awareness of potential interference may prevent unwanted misdiagnosis. KEY POINTS: • Contrast Media may interfere with clinical laboratory tests; therefore awareness of potential interference may prevent unwanted misdiagnosis. • Clinical Laboratory tests should be performed prior to radiological imaging with contrast media or alternatively, blood or urine collection should be delayed, depending on kidney function.

Keywords: Analytical chemistry; Clinical laboratory techniques; Clinical practice guideline; Contrast agents; Diagnostic error.

PubMed Disclaimer

Conflict of interest statement

The authors of this manuscript declare relationships with the following companies:

Aart J. van der Molen: Guerbet

Johannes G. Krabbe: none

Ilona A. Dekkers: Guerbet

Remy W.F. Geenen: none

Marie-France Bellin: is a member of the European Radiology Advisory Editorial Board but has not taken part in the review or selection process of this article.

Michele Bertolotto: none

Torkel B Brismar: is a member of the European Radiology Scientific Editorial Board but has not taken part in the review or selection process of this article.

Janne Cadamuro: none

Jean-Michel Correas: Bracco Imaging, Guerbet

Gertraud Heinz-Peer: none

Michel R. Langlois: none

Andreas H. Mahnken: none

Tomris Ozben: none

Carlo C. Quattrocchi: Bracco Imaging, Guerbet, Bayer Healthcare, GE Healthcare

Alexander Radbruch: none

Peter Reimer: none

Giles Roditi: none

Laura Romanini: none

Carmen Sebastià: none

Ana-Maria Simundic: none

Fulvio Stacul: none

Olivier Clement: Bracco Imaging, Guerbet, Bayer Healthcare

The contrast media companies Bayer Healthcare, Bracco Imaging, GE Healthcare, and Guerbet are consultants to the ESUR Contrast Media Safety Committee and participate in all scientific discussions but are not involved in any of the final recommendations.

Similar articles

Cited by

References

    1. Doorenbos CJ, Ozyilmaz A, van Wijnen M. Severe pseudohypocalcemia after gadolinium-enhanced magnetic resonance angiography. N Engl J Med. 2003;349(8):817–818. doi: 10.1056/NEJM200308213490822. - DOI - PubMed
    1. Otnes S, Fogh-Andersen N, Rømsing J, Thomsen HS. Analytical interference by contrast agents in biochemical assays. Contrast Media Mol Imaging. 2017;2017:1323802. doi: 10.1155/2017/1323802. - DOI - PMC - PubMed
    1. Morcos SK, Thomsen HS, Exley CM; Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) (2005) Contrast media: interactions with other drugs and clinical tests. Eur Radiol 15:1463-1468 - PubMed
    1. Dimopoulos MA, Moreau P, Terpos E, et al. Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Ann Oncol. 2021;32:309–322. doi: 10.1016/j.annonc.2020.11.014. - DOI - PubMed
    1. Quirós C, Cillero AI, Bretaña L, García M, Prieto B, Álvarez FV. In vivo interference of Ioversol in serum and urine capillary electrophoresis: an optimized protocol for sample collection. Clin Chem Lab Med. 2018;56:e53–e55. doi: 10.1515/cclm-2017-0509. - DOI - PubMed

LinkOut - more resources